Friday, July 29, 2016
Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV
An error occurred in a 15 July 2016 supplement article [MacBrayne CE and Kiser JJ. Pharmacologic Considerations in the Treatment of Hepatitis C Virus in Persons With HIV. Clin Infect Dis 2016; 63(S1):12–23]. In the second paragraph under the Velpatasvir section, the second sentence should state that the agents should be taken 4 hours before food, and not simultaneously. The online version of the article has been corrected but the print version has the original wording.
The authors apologize for this error.